Free Trial

Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

$11.57
-0.01 (-0.09%)
(As of 07/2/2024 ET)
Today's Range
$11.40
$11.70
50-Day Range
$11.58
$18.35
52-Week Range
$11.40
$31.32
Volume
25.93 million shs
Average Volume
14.66 million shs
Market Capitalization
$9.99 billion
P/E Ratio
N/A
Dividend Yield
8.64%
Price Target
$18.07

Walgreens Boots Alliance MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.88 Rating Score
Upside/​Downside
56.2% Upside
$18.07 Price Target
Short Interest
Bearish
6.19% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.09
Upright™ Environmental Score
News Sentiment
-0.10mentions of Walgreens Boots Alliance in the last 14 days
Based on 89 Articles This Week
Insider Trading
Acquiring Shares
$170,430 Bought Last Quarter
Proj. Earnings Growth
1.70%
From $2.94 to $2.99 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.86 out of 5 stars

Retail/Wholesale Sector

11th out of 194 stocks

Drug Stores & Proprietary Stores Industry

2nd out of 4 stocks

WBA stock logo

About Walgreens Boots Alliance Stock (NASDAQ:WBA)

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000  doctors, health centers,  pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued. 

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

WBA Stock Price History

WBA Stock News Headlines

Adobe logo sign
3 Recent Stock Buybacks: Adobe, Marathon, and FedEx Lead the Way (WBA)
Three companies are starting to buy back stock this quarter, and financial strength in their companies lets them do this. Wall Street analysts see more upside
walgreens logo sign on storefront
What's Behind Walgreens Stock Plunge: What Investors Can Do Next
After years of a downtrend in their price, shares of Walgreens Boots Alliance Inc. NASDAQ: WBA have thrown in the towel this time. In a single day, the stock is down over 25% in a sign that can't be taken in any other way than a ‘run' message.
The Only Retirement Stock You'll Ever Need? Discover Now
There is a little region of America called Loudoun County. The value of each square mile has shot up close to $10 billion... It's also the source of the single greatest investment opportunity of our generation...
walgreens logo sign on storefront
What's Behind Walgreens Stock Plunge: What Investors Can Do Next (WBA)
Shares of Walgreens are down over 25% in a single day, pushing investors to seek an answer. There is a lateral play that can be considered for income here
Ocala, Florida 4-9-2024 Walgreens Drug Store red logo, signage, facade exterior entrance with blue sky and clouds background. Walgreens is an American company that operates a pharmacy store chain.
Walgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts Ahead
Walgreens Boots Alliance NASDAQ: WBA is a global leader in integrated healthcare, pharmacy, and retail. The company recently released its earnings report for the third quarter of 2024, raising questions about its ability to navigate a challenging market environment and achieve sustainable growth.
Ocala, Florida 4-9-2024 Walgreens Drug Store red logo, signage, facade exterior entrance with blue sky and clouds background. Walgreens is an American company that operates a pharmacy store chain.
Walgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts Ahead
Walgreens Boots Alliance faces market challenges, leading to missed earnings expectations and strategic changes to improve profitability.
A currency trader passes by the screen showing the Korea Composite Stock Price Index…
Stock market today: Asian shares advance ahead of U.S. inflation report
Asian shares have advanced as traders look ahead to a key report on inflation that could influence the Federal Reserve’s next move on interest rates
Financial markets news icon
How major US stock indexes fared Thursday, 6/27/2024
Stocks inched higher on Wall Street as markets wait for a key report on inflation
The Only Retirement Stock You'll Ever Need? Discover Now
There is a little region of America called Loudoun County. The value of each square mile has shot up close to $10 billion... It's also the source of the single greatest investment opportunity of our generation...
Jen Trejo holds a photo of her son Christopher as she is comforted outside the Supreme Court where …
The legal odyssey for OxyContin maker Purdue Pharma and its owners is complex. Here's what to know
The Supreme Court has rejected a settlement for OxyContin maker Purdue Pharma and members of the Sackler family who own the company
Walgreens says a quarter of US stores are underperforming and it plans to shutter a significant number within 3 years
Walgreens says a quarter of US stores are underperforming and it plans to shutter a significant number within 3 years
A Walgreens store in Bradenton, Fla
Walgreens woes continue with earnings miss, guidance cut and plans to shutter more stores
Walgreens shares tumbled early Thursday after the drugstore chain signaled that more store closings are on the way, missed earnings expectations for its third quarter and cut its annual forecast
Walgreens: Yielding Over 8% Following The Earnings Drop
Walgreens Boots Alliance (NASDAQ:WBA) Price Target Cut to $13.00
Walgreens Boots Alliance (NASDAQ:WBA) Trading Up 3.5%
See More Headlines
Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/12 Dividend
5/20/2024
Dividend Payable
6/12/2024
Last Earnings
6/27/2024
Today
7/02/2024
Fiscal Year End
8/31/2024
Next Earnings (Estimated)
10/10/2024

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
331,000
Year Founded
2014

Price Target and Rating

Average Stock Price Target
$18.07
High Stock Price Target
$30.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+64.5%
Consensus Rating
Reduce
Rating Score (0-4)
1.88
Research Coverage
16 Analysts

Profitability

Net Income
$-3,080,000,000.00
Pretax Margin
-9.34%

Debt

Sales & Book Value

Annual Sales
$145.53 billion
Cash Flow
$6.31 per share
Book Value
$32.78 per share

Miscellaneous

Free Float
713,065,000
Market Cap
$9.97 billion
Optionable
Optionable
Beta
0.72

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Stefano Pessina (Age 83)
    Executive Chairman of the Board
    Comp: $66.73k
  • Mr. Manmohan Mahajan (Age 44)
    Executive VP & Global CFO
    Comp: $1.16M
  • Ms. Ornella BarraMs. Ornella Barra (Age 71)
    Executive VP & COO of International
    Comp: $1.44M
  • Mr. Timothy C. WentworthMr. Timothy C. Wentworth (Age 64)
    CEO & Director
  • Mr. Todd D. Heckman (Age 50)
    Senior VP, Global Controller & Chief Accounting Officer
  • Dr. Neal Joseph Sample Ph.D. (Age 49)
    Executive VP & Chief Information Officer
  • Ms. Tiffany Ann Kanaga
    Vice President of Global Investor Relations
  • Mr. Matthew D'Ambrosio (Age 54)
    Senior VP and Global Chief Compliance & Ethics Officer
  • Ms. Lanesha T. Minnix (Age 49)
    Executive VP & Global Chief Legal Officer
  • Ms. Elizabeth L. Burger (Age 53)
    Executive VP & Chief Human Resources Officer

Should I Buy Walgreens Boots Alliance Stock? WBA Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Walgreens Boots Alliance, Inc.:

  • Walgreens Boots Alliance reported earnings per share of $1.20 for the quarter, surpassing the consensus estimate by $0.38, indicating strong financial performance.
  • The company had a positive return on equity of 12.11%, showcasing efficient utilization of shareholder funds to generate profits.
  • Recent insider transactions, such as Director and CFO stock purchases, signal confidence in the company's future prospects, which can be viewed positively by investors.
  • Walgreens Boots Alliance's quarterly revenue increased by 6.3% compared to the same period last year, demonstrating growth potential.
  • The company pays a quarterly dividend with a yield of 6.39%, providing investors with a steady income stream.

Cons

Investors should be bearish about investing in Walgreens Boots Alliance, Inc. for these reasons:

  • The company's net margin was negative at -4.18%, indicating challenges in profitability and cost management.
  • Walgreens Boots Alliance's dividend payout ratio is currently -14.29%, suggesting that the company may not be utilizing its earnings effectively to distribute dividends.
  • Institutional inflows and outflows show mixed investor sentiment, with some institutions increasing their stake while others reducing it, reflecting uncertainty in the market regarding the company's future performance.
  • While the stock price may seem attractive, investors should consider the overall financial health and long-term growth prospects of the company before making investment decisions.
  • Analysts forecasted earnings per share of 3.21 for the current fiscal year, which may indicate challenges in meeting expectations and sustaining growth.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, June 28, 2024. Please send any questions or comments about these Walgreens Boots Alliance pros and cons to contact@marketbeat.com.

WBA Stock Analysis - Frequently Asked Questions

Should I buy or sell Walgreens Boots Alliance stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 4 sell ratings, 10 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" WBA shares.
View WBA analyst ratings
or view top-rated stocks.

What is Walgreens Boots Alliance's stock price target for 2024?

16 equities research analysts have issued 12-month price targets for Walgreens Boots Alliance's stock. Their WBA share price targets range from $9.00 to $30.00. On average, they anticipate the company's share price to reach $18.07 in the next year. This suggests a possible upside of 56.2% from the stock's current price.
View analysts price targets for WBA
or view top-rated stocks among Wall Street analysts.

How have WBA shares performed in 2024?

Walgreens Boots Alliance's stock was trading at $26.11 at the start of the year. Since then, WBA stock has decreased by 55.7% and is now trading at $11.57.
View the best growth stocks for 2024 here
.

When is Walgreens Boots Alliance's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 10th 2024.
View our WBA earnings forecast
.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) posted its earnings results on Thursday, June, 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by $0.05. The pharmacy operator earned $36.40 billion during the quarter, compared to analysts' expectations of $35.94 billion. Walgreens Boots Alliance had a positive trailing twelve-month return on equity of 12.63% and a negative net margin of 3.99%. The firm's revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.00 EPS.
Read the conference call transcript
.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance announced a quarterly dividend on Thursday, April 25th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.25 per share on Wednesday, June 12th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.64%. The ex-dividend date of this dividend is Monday, May 20th.
Read our dividend analysis for WBA
.

Is Walgreens Boots Alliance a good dividend stock?

Walgreens Boots Alliance (NASDAQ:WBA) pays an annual dividend of $1.00 per share and currently has a dividend yield of 8.20%. WBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for WBA.

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?

Walgreens Boots Alliance issued an update on its FY24 earnings guidance on Thursday, June, 27th. The company provided earnings per share (EPS) guidance of $2.80-$2.95 for the period, compared to the consensus earnings per share estimate of $3.20.

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by many different institutional and retail investors. Top institutional shareholders include GAMMA Investing LLC (0.00%) and Massmutual Trust Co. FSB ADV (0.00%). Insiders that own company stock include Inderpal S Bhandari, John Patrick Driscoll, Kevin M Ban, Manmohan Mahajan, Nancy M Schlichting, Nancy M Schlichting, Richard P Gates, Rosalind G Brewer, Timothy C Wentworth, Valerie B Jarrett and Walgreens Boots Alliance, Inc.
View institutional ownership trends
.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Walgreens Boots Alliance have any subsidiaries?
The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, Bond Drug Company of Illinois LLC, Boots Opticians Professional Services Limited, Boots Properties Limited, Boots Property Partnerships, Boots Retail (Ireland) Limited, Boots Retail (Thailand) Limited, Boots UK Limited, Duane Reade, Farmacias Benavides S.A.B. de C.V., Innovation Associates Inc, Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Shields Health Solutions, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Specialty Pharmacy LLC, and Waltrust Properties Inc..
Read More
This page (NASDAQ:WBA) was last updated on 7/3/2024 by MarketBeat.com Staff

From Our Partners